Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug ... of these medications for maternal and child ... The Nose Knows: Nasal Swab Detects Asthma Type ...

Medicare is set to negotiate with manufacturers on 15 drugs in an effort to lower their prices for consumers nationwide. The ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...